Namir Shaabani

7PUBLICATIONS
59CO-AUTHORS
Innate immunityMedical molecular engineering of nucleic acids and proteinsCheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)Infectious agents
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 06, 2026
Apoptotic-Cell Accumulation and Mertk Expression Are Linked to Diminished Antiviral CD8+ T Cell Immunity in Chronic Infections.

|Aug 15, 2023
Broadening a SARS-CoV-1-neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution.

Fangzhu Zhao, Meng Yuan, Celina Keating

|Feb 08, 2022
A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection.

Panpan Zhou, Meng Yuan, Ge Song

|Jun 04, 2021
Drug repurposing screens identify chemical entities for the development of COVID-19 interventions.

Malina A Bakowski, Nathan Beutler, Karen C Wolff

|Mar 27, 2021
IFNAR1 signaling in NK cells promotes persistent virus infection.

Zhe Huang, Seung Goo Kang, Yunqiao Li

|Apr 01, 2020
Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology.

Paul David, Malgorzata Drabczyk-Pluta, Eva Pastille

Pageof 2

Frequent Collaborators

4 joint publications

John R Teijaro

3 joint publications

Dennis R Burton

2 joint publications

Zhe Huang

2 joint publications

Deli Huang